Ricerca avanzata

Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 1998 Febbraio;39(1) > The Journal of Cardiovascular Surgery 1998 Febbraio;39(1):99-102

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOTHE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632

Periodicità: Bimestrale

ISSN 0021-9509

Online ISSN 1827-191X

 

The Journal of Cardiovascular Surgery 1998 Febbraio;39(1):99-102

CARDIAC PAPERS 

 ORIGINAL ARTICLES

The Sorin Bicarbon valve: clinical eval­u­a­tion in Israel

Borman J. B., Deviri E., Bitran D.*, Silberman Sh.*, Locker Ch.***, Yakirevich V.***, Sharoni R.**, Uretzky G.**

From Bikur Cholim Hospital, Jerusalem
* Sha'arei Tzedek Medical Center, Jerusalem
** Carmel Medical Center, Haifa
*** Ichilov Medical Center, Tel Aviv, Israel

Background. Four col­lab­o­rat­ing cen­ters ­pooled their ­results with the Sorin Bicarbon Bileaflet valve.
Material and methods. Between 6/91 and 11/95, 431 ­patients, 235 males and 196 ­females, under­went valve replace­ment using the new Sorin pros­the­sis; age range: 16-88, mean 61.4 yrs. Operations: AVR - 206, MVR - 177, TVR - 1, DVR - 47. Additional pro­ce­dures - 139: CAB - 117, valve ­repair - 22. AV sizes: 19-27, MV sizes: 21-33.
Results. Thirty day mor­tal­ity was 4.3%. Early com­pli­ca­tions includ­ed: CVA - 1.4%, +ve blood cul­ture - 2%, reop for bleed­ing - 5%. Late com­pli­ca­tions: infec­tive endo­car­ditis - 2.3%, valve throm­bo­sis - 0.2%, throm­boem­bo­li - 2.5%, major bleed­ing - 1.6%, reop­er­a­tion - 3%, late ­deaths (all caus­es) - 4.3%. No struc­tu­ral dete­ri­ora­tion has been report­ed with this valve and accept­able gra­dients have been ­observed. Hemolysis is neg­li­gible.
Conclusions. Based on this inter­me­di­ate expe­ri­ence the Sorin Bicarbon pros­the­sis is well-­designed with good hemo­dy­nam­ic prop­er­ties, and an accept­ably low inci­dence of com­pli­ca­tions.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina